Research & Development

300万彩票2014体育彩票休市2013福利彩票开奖79期强劲非农助美元一飞冲天 本周鲍威尔证词料再掀波澜


  孟度也料定,唯有小蟲嫁過來,他的兩個傻兒子,在他夫婦百年之後才有好日子過。   劉陵慣例是不說話的,只是笑吟吟的指揮侍女們給各位族長添肉倒酒,在談論一段時間的國事之後,她就會命令從西域弄來的舞姬,樂師們演奏音樂,跳一段美妙的歌舞。300万彩票 2014体育彩票休市   他們只想跟小蟲長久的在一起……   劉陵笑道︰“還真是雲氏做派,先傳達你家主子的聲音,而後才傳達陛下的旨意,就這一條,只要傳到漢地,你家主子就會死無葬身之地!”2013福利彩票开奖79期   雖然在遠離牛羊的地方,蚊蟲很少,狗子卻不願意跑到那麼遠的地方,草原上的狼群正在那一帶窺伺牧場,他不想拿自己的身體去喂狼。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo